Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

ArmaGen Technologies
914 Colorado Ave.
Santa Monica, CA 90401
Phone: 310-917-1275
http://www.armagen.com

ArmaGen Technologies is both a platform technology company and a products company. The platform technology produces IgG fusion proteins formed by fusion of a recombinant protein therapeutic, which does not cross the BBB to an IgG. The IgG domain of the fusion protein is a genetically engineered monoclonal antibody, which crosses the human BBB via transport on endogenous BBB receptors.

Key Contact
Name
Ruben J. Boado
Title
President
Funding Events

Date
Amount
Type
Investors
Valuation
11/30/12 $17,000,000 Series A Boehringer Ingelheim Venture Fund
Mitsui Global Investment
Shire Strategic Investment Group
Takeda Ventures
undisclosed


Featured Reading